Quick Takeaways
- UTMD - UTAH MEDICAL PRODUCTS INC financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Invested Capital 27%.
- Info
- Insider Trading
- Financials
- Holders
UTAH MEDICAL PRODUCTS INC financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- UTMD on Nasdaq
- Location
- Midvale, UT
- Fiscal year end
- 31 December
- Latest financial report
- 27 Mar 2026
What Changed
- Return On Invested Capital YoY change: <span class="text-red-600">-13%</span>.
- Most recent SEC facts end date: 26 Mar 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-03-26) highlights Return On Invested Capital 26.6%, Return On Equity 9.5%, and Return On Assets 6.5%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
49.3/100
Caution Confidence high
Return On Invested Capital
27%
Metric score 100.0/100
Return On Equity
9.5%
Metric score 9.0/100
Return On Assets
6.5%
Metric score 56.3/100
Financial Health
- Current Ratio
- 37.62x
- Quick Ratio
- 34.36x
- Debt to Equity
- 0x
Strengths
Return On Invested Capital, Operating Margin, and Debt-to-equity
Watchpoints
Return On Equity, Current Ratio, and Quick Ratio
Key metrics snapshot
Return On Invested Capital
27%
YoY: -13%
Return On Equity
9.5%
YoY:
Industry median: -18% (n=176)
Return On Assets
6.5%
YoY:
Industry median: -36% (n=175)
Operating Margin
31%
YoY: -11%
Industry median: -17% (n=127)
Current Ratio
37.62x
YoY: +47%
Industry median: 2.36x (n=176)
Quick Ratio
34.36x
YoY: +48%
Industry median: 1.88x (n=146)
Debt-to-equity
0x
YoY: -21%
Industry median: 0.39x (n=162)
Revenues YoY
-5.8%
YoY:
Industry median: 13% (n=42)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Invested Capital | 27% | -13% |
| Return On Equity | 9.5% | |
| Return On Assets | 6.5% | |
| Operating Margin | 31% | -11% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 37.62x | +47% |
| Quick Ratio | 34.36x | +48% |
| Debt-to-equity | 0x | -21% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -5.8% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 3,185,025 | -2.9% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY